166
+2.47%
Close of 9 Nov 2026, in IDR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Jayamas Medica Industri TBK PT
Its shares trade on IDX under the ticker OMED.JK. It has been listed since 8 November 2022. In the fiscal year to 31 December 2025, it reported revenue of IDR 2.06trn and net income of IDR 366.95bn. At that date it held total assets of IDR 3.20trn and shareholders' equity of IDR 2.72trn.
PT Jayamas Medica Industri engages in the manufacture, wholesale, and retail trade of medical devices. The firm's segments include Manufacturing, Distribution and Retail. The Manufacturing segment is involved in the manufacture of medical supplies and equipment. The Distribution segment is involved with the large-scale distribution of medical supplies and equipment at strategic locations. The Retail segment is involved with the retail of medical supplies and equipment through Medicom stores and online platforms. Its products category includes medical disposables and consumables, antiseptic and dialysis, diagnostics and equipment’s, walking aids and rehabilitation care, biotechnology and laboratory, and hospital furniture’s. Antiseptics and disinfectants are both used as germ-killing cleaning fluids in both health and daily use. Its subsidiaries include PT Intisumber Hasil Sempurna Global (IHSG) and PT Inti Medicom Retailindo.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 8 Nov 2022
- Employees
- 1,163
- Website
- onemed.co.id ↗
Leadership
Pay as last reported
- Dr. Yacobus Jemmy HartantoPresident Commissioner
- Dr. Herlien Sri ArianiPresident Director
- Mr. Eka SuwignyooFinance Director
- Mr. Louis HartantoMarketing and Sales Director
- Mr. Leonard HartantoDirector of Operations
- Mrs. Siane SoetantoCommissioner
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Company operates in Health Care sector with multiple business segments including Manufacturing, Distribution, and Retail.
- Owns subsidiaries PT Intisumber Hasil Sempurna Global and PT Inti Medicom Retailindo.
- Provides a range of medical products including disposables, antiseptics, diagnostics, and rehabilitation care.
Weaknesses
- City location is unknown, which may affect operational transparency.
- No specific information on financial performance or market share provided.
- IPO date is 2022-11-08, indicating a relatively new public company.
Opportunities
- Expanding retail through Medicom stores and online platforms could increase market reach.
- Growing demand for medical supplies and equipment in the Health Care sector.
- Potential for expansion into new product categories such as biotechnology and laboratory equipment.
Threats
- Reliance on a single sector (Health Care) may increase vulnerability to industry downturns.
- Competition in medical device manufacturing and distribution could intensify.
- Unverified source description may lead to inaccurate market positioning.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.